Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Henry

Showing results (11-20 of 265) with videos related to

Pageof 27
Sort By:
The International Journal of Pharmacy Practice|May 3, 2025
Legal requirements for pharmacist supervision in the UKDavid Henry Reissner
JAMA|September 14, 2006
Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2Patricia McGettigan, David Henry
The New England Journal of Medicine|March 1, 2005
Medical research and the news mediaPatricia McGettigan, David Henry
Plos Medicine|April 7, 2006
The fight against disease mongering: generating knowledge for actionRay Moynihan, David Henry
Plos Medicine|February 21, 2013
Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countriesPatricia McGettigan, David Henry
International Journal of Hematologic Oncology|October 11, 2018
Isolated hypoglossal nerve palsy as a presenting symptom of metastatic peripheral T-cell lymphoma - not otherwise specified (PTCL-NOS): a unique case & a review of the literatureEmily Bryer, David Henry
International Journal of Clinical Practice. Supplement|May 2, 2003
Epidemiology overview of gastrointestinal and renal toxicity of NSAIDsDavid Henry, Patricia McGettigan
Plos Medicine|October 8, 2011
Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studiesPatricia McGettigan, David Henry
Lancet (London, England)|February 8, 2003
Bridges to IranDavid Henry, Glenn Salkeld
BMJ (Clinical Research Ed.)|September 18, 2015
Liberating the data from clinical trialsDavid Henry, Tiffany Fitzpatrick
Pageof 27

Showing results (11-20 of 265) with videos related to

Sort By:
Pageof 27
The International Journal of Pharmacy Practice|May 3, 2025
Legal requirements for pharmacist supervision in the UKDavid Henry Reissner
JAMA|September 14, 2006
Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2Patricia McGettigan, David Henry
The New England Journal of Medicine|March 1, 2005
Medical research and the news mediaPatricia McGettigan, David Henry
Plos Medicine|April 7, 2006
The fight against disease mongering: generating knowledge for actionRay Moynihan, David Henry
Plos Medicine|February 21, 2013
Use of non-steroidal anti-inflammatory drugs that elevate cardiovascular risk: an examination of sales and essential medicines lists in low-, middle-, and high-income countriesPatricia McGettigan, David Henry
International Journal of Hematologic Oncology|October 11, 2018
Isolated hypoglossal nerve palsy as a presenting symptom of metastatic peripheral T-cell lymphoma - not otherwise specified (PTCL-NOS): a unique case & a review of the literatureEmily Bryer, David Henry
International Journal of Clinical Practice. Supplement|May 2, 2003
Epidemiology overview of gastrointestinal and renal toxicity of NSAIDsDavid Henry, Patricia McGettigan
Plos Medicine|October 8, 2011
Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studiesPatricia McGettigan, David Henry
Lancet (London, England)|February 8, 2003
Bridges to IranDavid Henry, Glenn Salkeld
BMJ (Clinical Research Ed.)|September 18, 2015
Liberating the data from clinical trialsDavid Henry, Tiffany Fitzpatrick
Pageof 27